MedTrace Logo

COVADIS Pilot Trial: COseal in Ventricular Assist DevIceS

NCT01244321 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2015-01-29

No results posted yet for this study

Summary

The objective of this controlled, non-randomized, single-center pilot study (CoSeal arm prospective)study is to evaluate the efficacy of the synthetic surgical hydrogel CoSeal® in the prevention of cardiac adhesion formation in patients submitted to VAD procedures.

Conditions

  • End-stage Heart Failure Awaiting VAD Implantation

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • German Heart Institute

    lead OTHER

Principal Investigators

  • Roland Hetzer, MD, PhD · Deutsches Herzzentrum Berlin, Germany

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2017-12-31
Completion
2018-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01244321 on ClinicalTrials.gov